Specificity of Antibody-Dependent Cellular Cytotoxicity in Sera from Human Immunodeficiency Virus Type 2-Infected Individuals
- 1 September 1993
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 9 (9) , 883-889
- https://doi.org/10.1089/aid.1993.9.883
Abstract
ADCC activity in sera from HIV-2-infected individuals was monitored against HIV-1IIIB, SIVmac, and three different HIV-2 strains. The sera mediated ADCC against the HIV-2 strains in high frequencies and reacted equally well with SIVmac, whereas no cross-reactivity was seen against HIV-1IIIB. The degree of antigenic similarities between the virus strains was also evaluated in order to estimate the variability of ADCC target regions. The SIVmac strain and two of the HIV-2 strains were antigenically more similar to each other whereas another HIV-2 strain appeared more distantly related with regard to ADCC target regions. Although strain-specific ADCC was present in some HIV-2-positive sera, HIV-2 ADCC was more broadly reactive and appeared in higher frequencies against these specific strains than has been previously shown for HIV-1 ADCC in a group of four HIV-1 strains. The difference was, however, not significant. To further delineate target regions for ADCC the sera were tested against peptides representing different regions of the HIV-2 envelope protein. The V3 region and the C-terminal end of gp125 were thus suggested to be involved in ADCC. Target regions for HIV-2-specific ADCC may only partly overlap with HIV-2-neutralizing regions since the two activities were not always present in the same sera. Characterization of broadly reacting immune responses like HIV-2-specific ADCC and identification of their specific target epitopes is essential for the development of an efficient AIDS vaccine.Keywords
This publication has 20 references indexed in Scilit:
- Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related diseaseVirology, 1991
- Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120Science, 1991
- Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progressionJournal of Clinical Immunology, 1989
- Cross-Neutralizing Antibodies Against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a New Isolate SBL-K135)AIDS Research and Human Retroviruses, 1989
- Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitroJournal of Immunological Methods, 1987
- HIV-specific cytotoxic T lymphocytes in seropositive individualsNature, 1987
- AIDS virus-specific cytotoxic T lymphocytes in lung disordersNature, 1987
- A New Human Retrovirus Isolate of West African Origin (SBL-6669) and Its Relationship to HTLV-IV, LAV-II, and HTLV-IIIBAIDS Research and Human Retroviruses, 1987
- Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patientsNature, 1985
- HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complexNature, 1985